Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
LoRusso PM, Sekulic A, Sosman JA, Liang WS, Carpten J, Craig DW, Solit DB, Bryce AH, Kiefer JA, Aldrich J, Nasser S, Halperin R, Byron SA, Pilat MJ, Boerner SA, Durecki D, Hendricks WPD, Enriquez D, Izatt T, Keats J, Legendre C, Markovic SN, Weise A, Naveed F, Schmidt J, Basu GD, Sekar S, Adkins J, Tassone E, Sivaprakasam K, Zismann V, Calvert VS, Petricoin EF, Fecher LA, Lao C, Eder JP, Vogelzang NJ, Perlmutter J, Gorman M, Manica B, Fox L, Schork N, Zelterman D, DeVeaux M, Joseph RW, Cowey CL, Trent JM. LoRusso PM, et al. PLoS One. 2021 Apr 7;16(4):e0248097. doi: 10.1371/journal.pone.0248097. eCollection 2021. PLoS One. 2021. PMID: 33826614 Free PMC article. Clinical Trial.
Vascular targeting agents.
Pilat MJ, McCormick J, LoRusso PM. Pilat MJ, et al. Among authors: lorusso pm. Curr Oncol Rep. 2004 Mar;6(2):103-10. doi: 10.1007/s11912-004-0021-6. Curr Oncol Rep. 2004. PMID: 14751087 Review.
A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C. Markovic SN, et al. Among authors: lorusso p. Cancer. 2005 Jun 15;103(12):2584-9. doi: 10.1002/cncr.21108. Cancer. 2005. PMID: 15887220 Free article. Clinical Trial.
Vascular disrupting agents.
Pilat MJ, Lorusso PM. Pilat MJ, et al. Among authors: lorusso pm. J Cell Biochem. 2006 Nov 1;99(4):1021-39. doi: 10.1002/jcb.20783. J Cell Biochem. 2006. PMID: 16927308
Clinical experience of MEK inhibitors in cancer therapy.
Wang D, Boerner SA, Winkler JD, LoRusso PM. Wang D, et al. Among authors: lorusso pm. Biochim Biophys Acta. 2007 Aug;1773(8):1248-55. doi: 10.1016/j.bbamcr.2006.11.009. Epub 2006 Nov 16. Biochim Biophys Acta. 2007. PMID: 17194493 Free article. Review.
341 results